Integrated Biopharma Inc (INBP) Earnings Report, Financial Results, Financial analysis

Integrated Biopharma Inc reported break-even for the third quarter of 2023 compare to earnings per share of $0.03 recorded in the same quarter a year ago a decrease from $0.03 realized in II. Quarter (Dec 31 2022).

*third quarter of 2023*
Earnings Per Share	Revenues
$ 0	$ 13 Mill
$-0.03	$-3M -16.22 %

Integrated Biopharma Inc's Revenue fell by -16.22 % in third quarter of 2023 (Mar 31 2023) year on year, to $13 million and advanced by 6.89 % sequentially.

Integrated Biopharma Inc is Expected to report next financial results on September 12, 2023.

More on INBP's Income Statement

INBP's NET INCOME

Integrated Biopharma Inc's net income of $0.016 million in the third quarter of 2023 decreased by -97.99 % from net earnings of $0.797 million achieved in III. Quarter a year ago.

Sequentially Company turn into Profitability from net loss of $-0.055 million recorded in previous quarter.

More on INBP's Growth

Integrated Biopharma Inc Inventories
Inventories declined by -24.12 % to $9.94 million from III. Quarter a year ago, sequentially inventories fell by -3.19 %. INBP's Cash flow In thethird quarter of 2023 company's net cash flow was $1 million, capital expenditures grew by -88.81%, to $0 millions compare to same quarter a year ago and rose by -50.00% from II. Quarter (Dec 31 2022).

More on INBP's Cash flow Statement

Earnings quality

Integrated Biopharma Inc does not pay out common stock dividend.

In trailing twelve-month period Integrated Biopharma Inc earned $ 0.17 cash per share, on a free-cash flow basis 213.73 % of net earning per share.

Book value fell by -99.90 % sequentially to $0.63 per share.
Tangible Book value fell to $ 0.63 per share from $ 622.78.

Company issued 29.92 million shares or 99,900.00 % in Mar 31 2023.
Interest Coverage Ratio was 7.84. Debt Coverage Ratio was 6.57.

• More on INBP's Dividends

Market Capitalization (Millions)	11
Shares Outstanding (Millions)	30
Total Debt (Millions $)	0
Revenue (TTM) (Millions $)	51
Net Income (TTM) (Millions $)	1
Cash Flow (TTM) (Millions $)	2
Capital Exp. (TTM) (Millions $)	0
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-

Earnings quality

Integrated Biopharma Inc does not pay out common stock dividend.

In trailing twelve-month period Integrated Biopharma Inc had $ 0.17 cash flow per share, on a free-cash flow basis 213.73 % of net earning per share.

Book value fell by -99.90 % sequentially to $0.63 per share.
Tangible Book value fell to $ 0.63 per share from $ 622.78.

Company issued 29.92 million shares or 99,900.00 % in Mar 31 2023.
Interest Coverage Ratio was 7.84. Debt Coverage Ratio was 6.57.

• More on INBP's Balance Sheets

Market Capitalization (Millions)	11
Shares Outstanding (Millions)	30
Total Debt (Millions $)	0
Revenue (TTM) (Millions $)	51
Net Income (TTM) (Millions $)	1
Cash Flow (TTM) (Millions $)	2
Capital Exp. (TTM) (Millions $)	0
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-

Integrated Biopharma Inc

INBP's Financial Statements and Analysis